Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Gilmore

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
RSC Medicinal Chemistry|November 15, 2021
Design, synthesis, and antibacterial activity of <i>N</i>-(trifluoromethyl)phenyl substituted pyrazole derivativesIbrahim Saleh, Hansa Raj Kc, Subrata Roy, et al.
Molecules (Basel, Switzerland)|June 19, 2020
Synthesis and Antimicrobial Studies of Coumarin-Substituted Pyrazole Derivatives as Potent Anti-<i>Staphylococcus aureus</i> AgentsRawan Alnufaie, Hansa Raj Kc, Nickolas Alsup, et al.
Journal of Food Protection|January 7, 2012
Characterization of Staphylococcus aureus isolates from retail chicken carcasses and pet workers in Northwest ArkansasIrene Hanning, David Gilmore, Sean Pendleton, et al.
ACS Omega|September 12, 2019
Synthesis and Antimicrobial Studies of 4-[3-(3-Fluorophenyl)-4-formyl-1<i>H</i>-pyrazol-1-yl]benzoic Acid and 4-[3-(4-Fluorophenyl)-4-formyl-1<i>H</i>-pyrazol-1-yl]benzoic Acid as Potent Growth Inhibitors of Drug-Resistant BacteriaJedidiah Whitt, Cameron Duke, Mohamad Akbar Ali, et al.
The Journal of Antibiotics|July 1, 2020
Design and synthesis of 4-[4-formyl-3-(2-naphthyl)pyrazol-1-yl]benzoic acid derivatives as potent growth inhibitors of drug-resistant Staphylococcus aureusRawan Alnufaie, Nickolas Alsup, Hansa Raj Kc, et al.
Bioorganic & Medicinal Chemistry Letters|January 10, 2017
Synthesis and antimicrobial studies of novel derivatives of 4-(4-formyl-3-phenyl-1H-pyrazol-1-yl)benzoic acid as potent anti-Acinetobacter baumannii agentsDevin Allison, Evan Delancey, Hunter Ramey, et al.
Molecules (Basel, Switzerland)|June 1, 2019
Synthesis of Hydrazone Derivatives of 4-[4-Formyl-3-(2-oxochromen-3-yl)pyrazol-1-yl]benzoic acid as Potent Growth Inhibitors of Antibiotic-resistant <i>Staphylococcus aureus</i> and <i>Acinetobacter baumannii</i>Jedidiah Whitt, Cameron Duke, Anthony Sumlin, et al.
Journal of Nuclear Medicine Technology|August 16, 2014
Examining the nuclear medicine advanced associate: past, present, and future-a white paper presented by members of the graduate stakeholders committee of the SNMMI technologist sectionMary Anne Owen, C David Gilmore, Robert Henkin, et al.
Journal of Nuclear Medicine Technology|August 16, 2014
Clinical research: the future of the molecular imaging technologist-a white paper presented by members of the graduate stakeholders committee of the SNMMI technologist sectionScott Holbrook, John Baldwin, C David Gilmore, et al.
Journal of Nuclear Medicine Technology|December 4, 2025
Role and Qualifications of Nuclear Medicine Technologists on the Theranostic TeamCybil J Nielsen, David Gilmore, Fernando Anleu, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
RSC Medicinal Chemistry|November 15, 2021
Design, synthesis, and antibacterial activity of <i>N</i>-(trifluoromethyl)phenyl substituted pyrazole derivativesIbrahim Saleh, Hansa Raj Kc, Subrata Roy, et al.
Molecules (Basel, Switzerland)|June 19, 2020
Synthesis and Antimicrobial Studies of Coumarin-Substituted Pyrazole Derivatives as Potent Anti-<i>Staphylococcus aureus</i> AgentsRawan Alnufaie, Hansa Raj Kc, Nickolas Alsup, et al.
Journal of Food Protection|January 7, 2012
Characterization of Staphylococcus aureus isolates from retail chicken carcasses and pet workers in Northwest ArkansasIrene Hanning, David Gilmore, Sean Pendleton, et al.
ACS Omega|September 12, 2019
Synthesis and Antimicrobial Studies of 4-[3-(3-Fluorophenyl)-4-formyl-1<i>H</i>-pyrazol-1-yl]benzoic Acid and 4-[3-(4-Fluorophenyl)-4-formyl-1<i>H</i>-pyrazol-1-yl]benzoic Acid as Potent Growth Inhibitors of Drug-Resistant BacteriaJedidiah Whitt, Cameron Duke, Mohamad Akbar Ali, et al.
The Journal of Antibiotics|July 1, 2020
Design and synthesis of 4-[4-formyl-3-(2-naphthyl)pyrazol-1-yl]benzoic acid derivatives as potent growth inhibitors of drug-resistant Staphylococcus aureusRawan Alnufaie, Nickolas Alsup, Hansa Raj Kc, et al.
Bioorganic & Medicinal Chemistry Letters|January 10, 2017
Synthesis and antimicrobial studies of novel derivatives of 4-(4-formyl-3-phenyl-1H-pyrazol-1-yl)benzoic acid as potent anti-Acinetobacter baumannii agentsDevin Allison, Evan Delancey, Hunter Ramey, et al.
Molecules (Basel, Switzerland)|June 1, 2019
Synthesis of Hydrazone Derivatives of 4-[4-Formyl-3-(2-oxochromen-3-yl)pyrazol-1-yl]benzoic acid as Potent Growth Inhibitors of Antibiotic-resistant <i>Staphylococcus aureus</i> and <i>Acinetobacter baumannii</i>Jedidiah Whitt, Cameron Duke, Anthony Sumlin, et al.
Journal of Nuclear Medicine Technology|August 16, 2014
Examining the nuclear medicine advanced associate: past, present, and future-a white paper presented by members of the graduate stakeholders committee of the SNMMI technologist sectionMary Anne Owen, C David Gilmore, Robert Henkin, et al.
Journal of Nuclear Medicine Technology|August 16, 2014
Clinical research: the future of the molecular imaging technologist-a white paper presented by members of the graduate stakeholders committee of the SNMMI technologist sectionScott Holbrook, John Baldwin, C David Gilmore, et al.
Journal of Nuclear Medicine Technology|December 4, 2025
Role and Qualifications of Nuclear Medicine Technologists on the Theranostic TeamCybil J Nielsen, David Gilmore, Fernando Anleu, et al.
Pageof 4